XML 75 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings Per Share (Note)
 6 Months Ended
Aug. 03, 2013
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]
NOTE 9 — Earnings Per Share

The Company calculates earnings per share ("EPS") under the guidance in ASC 260-10, "Earnings per Share," which clarifies that unvested share-based payment awards that contain nonforfeitable rights to receive dividends or dividend equivalents (whether paid or unpaid) are considered participating securities, and thus, should be included in the two-class method of computing EPS. Participating securities under this statement include the Company's unvested employee restricted stock awards with time-based vesting, which receive nonforfeitable dividend payments.
 
The calculation of EPS for common stock shown below excludes the income attributable to these unvested employee restricted stock awards from the numerator and excludes the dilutive impact of these shares from the denominator.
 
 
Thirteen Weeks Ended
 
Twenty-Six Weeks Ended
 
 
August 3, 2013
 
July 28, 2012
 
August 3, 2013
 
July 28, 2012
Numerator (in thousands):
 
 
 
 
 
 

 
 

Net income (loss) attributable to Christopher & Banks Corporation
 
$
(265
)
 
$
(2,197
)
 
$
364

 
$
(15,610
)
Income allocated to participating securities
 
—

 
—

 
(1
)
 
—

Net income (loss) available to common shareholders
 
$
(265
)
 
$
(2,197
)
 
$
363

 
$
(15,610
)
Denominator (in thousands):
 
 
 
 
 
 

 
 

Weighted average common shares outstanding - basic
 
36,215

 
35,631

 
36,219

 
35,616

Dilutive shares
 
—

 
—

 
895

 
—

Weighted average common and common equivalent shares outstanding - diluted
 
36,215

 
35,631

 
37,114

 
35,616

Net earnings (loss) per common share:
 
 
 
 
 
 

 
 

Basic
 
$
(0.01
)
 
$
(0.06
)
 
$
0.01

 
$
(0.44
)
Diluted
 
$
(0.01
)
 
$
(0.06
)
 
$
0.01

 
$
(0.44
)

 
Total stock options of approximately 3.2 million and 1.9 million were excluded from the shares used in the computation of diluted earnings per share for the thirteen and twenty-six weeks ended August 3, 2013 and July 28, 2012, respectively, as they were anti-dilutive.